These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2514517)

  • 21. [Experimental relation between histamine-sensitizing factor and the protective antigen of Bordetella pertussis].
    Jiménez Paredes J; Ruiz Puente J; González Pacheco M
    Salud Publica Mex; 1981; 23(6):621-9. PubMed ID: 6278660
    [No Abstract]   [Full Text] [Related]  

  • 22. Attempts at analysis of toxicity of pertussis vaccine. I. Body weight-decreasing toxicity in mice.
    Kurokawa M; Ishida S; Iwasa S; Asakawa S; Kuratsuka K
    Jpn J Med Sci Biol; 1968 Apr; 21(2):137-53. PubMed ID: 4299576
    [No Abstract]   [Full Text] [Related]  

  • 23. Is the mouse weight gain test outdated as a model for the assessment of pertussis toxicity?
    Straaten-van der Kappelle IV; van der Gun J; van der Ark A; Hendriksen C
    Dev Biol Stand; 1996; 86():344. PubMed ID: 8785984
    [No Abstract]   [Full Text] [Related]  

  • 24. [Toxicity of Bordetella pertussis suspensions associated with the preparation of pertussis vaccine].
    Raĭkher LI; Kalinina ES; Shafran MI; Khazina EKh; Aĭnbinder ZTs
    Zh Mikrobiol Epidemiol Immunobiol; 1983 Mar; (3):15-7. PubMed ID: 6303021
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of glutaraldehyde for the preparation of pertussis vaccine.
    Gupta RK
    Vaccine; 1990 Aug; 8(4):409-10. PubMed ID: 2118706
    [No Abstract]   [Full Text] [Related]  

  • 26. Comparative stabilities of glutaraldehyde & heat inactivated pertussis vaccine components of adsorbed DPT vaccine with different preservatives.
    Gupta RK; Saxena SN; Sharma SB; Ahuja S
    Indian J Med Res; 1992 Jan; 95():8-11. PubMed ID: 1577522
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pertussis serological potency test as an alternatively to the intracerebral mouse protection test.
    van der Ark A; van Straaten-van de Kappelle I; Hendriksen C; van de Donk H
    Dev Biol Stand; 1996; 86():271-81. PubMed ID: 8785956
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of a pertussis component vaccine in Japan.
    Sato Y; Kimura M; Fukumi H
    Lancet; 1984 Jan; 1(8369):122-6. PubMed ID: 6140441
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Investigation of an aerosol challenge model as alternative to the intracerebral mouse protection test for potency assay of whole cell pertussis vaccines.
    Canthaboo C; Xing D; Douglas A; Corbel M
    Biologicals; 2000 Dec; 28(4):241-6. PubMed ID: 11237360
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Collaborative study for the standardisation of the histamine sensitizing test in mice and the CHO cell-based assay for the residual toxicity testing of acellular pertussis vaccines.
    Xing D; Maes A; Behr-Gross ME; Costanzo A; Daas A; Buchheit KH
    Pharmeur Bio Sci Notes; 2010 Apr; 2010(1):51-63. PubMed ID: 20223190
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glutaraldehyde inactivated pertussis vaccine: a safe vaccine in the innocuity test.
    Gupta RK; Sharma SB; Ahuja S; Saxena SN
    Vaccine; 1987 Jun; 5(2):102-4. PubMed ID: 2440196
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of two serological methods for potency testing of whole cell pertussis vaccines.
    von Hunolstein C; Gomez Miguel MJ; Pezzella C; Scopetti F; Behr-Gross ME; Halder M; Hoffmann S; Levels L; van der Gun J; Hendriksen C
    Pharmeuropa Bio; 2008 Dec; 2008(1):7-18. PubMed ID: 19220977
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of different detoxification procedures on the residual pertussis toxin activities in vaccines.
    Yuen CT; Asokanathan C; Cook S; Lin N; Xing D
    Vaccine; 2016 Apr; 34(18):2129-34. PubMed ID: 26973066
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Temperature-induced changes in the sporicidal activity and chemical properties of glutaraldehyde.
    Thomas S; Russell AD
    Appl Microbiol; 1974 Sep; 28(3):331-5. PubMed ID: 4213869
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assay of pertussis vaccine reactivity factors by measurement of the paw swelling response, endotoxin and histamine-sensitizing factor.
    Vuolo AM; Lustigman B
    Biologicals; 1993 Mar; 21(1):45-52. PubMed ID: 8217117
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cell-Mediated and Humoral Immune Responses to Bordetella pertussis Inactivated Whole-Cells Encapsulated Alginate Microspheres as a New Vaccine Candidate.
    Dounighi NM; Shahcheraghi F; Razzaghi-Abyaneh M; Nofeli M; Zolfagharian H
    Curr Pharm Biotechnol; 2017; 18(7):585-593. PubMed ID: 28814229
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of the protective effects of the pertussis acellular vaccine with the component vaccine, which have different amounts of fimbriae, against the experimental aerosol infection of mice with Bordetella pertussis.
    Morokuma K; Ginnaga A; Nishihara T; Tsunoda S; Furukawa M; Aihara K; Sakoh M
    Dev Biol Stand; 1991; 73():223-32. PubMed ID: 1685713
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Toxicity tests on native and recombinant Bordetella pertussis adenylate cyclase toxin preparations.
    Hormozi K; Parton R; Coote J
    Dev Biol Stand; 1999; 101():147-54. PubMed ID: 10566788
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Isolation from Bordetella pertussis of protective antigen free from toxic activity and histamine sensitizing factor.
    Nagel J
    Nature; 1967 Apr; 214(5083):96-7. PubMed ID: 4291816
    [No Abstract]   [Full Text] [Related]  

  • 40. Effect of hyperreactivity to endotoxin on the toxicity of pertussis vaccine and pertussis toxin in mice.
    Sidey FM; Furman BL; Wardlaw AC
    Vaccine; 1989 Jun; 7(3):237-41. PubMed ID: 2781857
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.